The earnings call highlighted significant revenue growth and improved financial guidance, driven by a strong funding environment and lower cancellations, despite a decrease in backlog and modest net income growth. The sentiment is positive overall due to the outweighing positive financial metrics and outlook.

Company Guidance

During the Medpace Second Quarter 2025 Earnings Conference Call, the company provided optimistic guidance based on several favorable metrics. The CEO, August Troendle, highlighted a book-to-bill ratio of 1.03x for the quarter, with expectations of returning to above 1.15x in Q3. Revenue for Q2 2025 was reported at $603.3 million, marking a 14.2% increase from the previous year. The company raised its revenue guidance by $280 million at the midpoint, driven by accelerated project startups and a shift towards faster-burning therapeutic areas. The CFO, Kevin Brady, noted a 16.2% increase in EBITDA to $130.5 million for the quarter, with a margin of 21.6%. The company adjusted their full-year revenue guidance to a range of $2.42 billion to $2.52 billion, reflecting a growth of 14.7% to 19.5% over 2024. Medpace anticipates a 200 to 300 basis point increase in reimbursable costs as a percentage of revenue for the remainder of the year.

Increased Revenue and Guidance

Revenue for Q2 2025 was $603.3 million, a year-over-year increase of 14.2%. The revenue guidance for the full year 2025 has been raised by $280 million at the midpoint.

Strong EBITDA Growth

EBITDA for Q2 2025 was $130.5 million, a 16.2% increase compared to Q2 2024. On a constant currency basis, EBITDA increased by 18.5%.

Stable Funding Environment

Despite funding challenges, most clients secured sufficient funding for ongoing studies, leading to a stable to improving funding environment.

Low Cancellations and Strong Bookings

Cancellations were down across the pipeline, with award notifications strong and the highest backlog awards in the past 5 quarters. The book-to-bill ratio was 1.03x in Q2 2025.

Increased Share Repurchases

Medpace repurchased approximately 1.75 million shares for $518.5 million in Q2 2025, with $826.3 million remaining under the share repurchase authorization program.

Medpace Holdings (MEDP) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MEDP Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 27, 2025	2025 (Q3)	3.52 / -	3.01	―	―	―
Jul 21, 2025	2025 (Q2)	2.98 / 3.10	2.75	12.73% (+0.35)
Apr 21, 2025	2025 (Q1)	3.06 / 3.67	3.2	14.69% (+0.47)
Feb 10, 2025	2024 (Q4)	2.94 / 3.67	2.46	49.19% (+1.21)
Oct 21, 2024	2024 (Q3)	2.77 / 3.01	2.22	35.59% (+0.79)
Jul 22, 2024	2024 (Q2)	2.54 / 2.75	1.93	42.49% (+0.82)
Apr 22, 2024	2024 (Q1)	2.47 / 3.20	2.27	40.97% (+0.93)
Feb 12, 2024	2023 (Q4)	2.22 / 2.46	2.12	16.04% (+0.34)
Oct 23, 2023	2023 (Q3)	2.05 / 2.22	2.05	8.29% (+0.17)
Jul 24, 2023	2023 (Q2)	1.91 / 1.93	1.46	32.19% (+0.47)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MEDP Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 21, 2025	$308.88	$477.73	+54.67%
Apr 21, 2025	$288.99	$282.28	-2.32%
Feb 10, 2025	$354.51	$327.86	-7.52%
Oct 21, 2024	$352.92	$326.54	-7.47%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Medpace Holdings (MEDP) report earnings?

Medpace Holdings (MEDP) is schdueled to report earning on Oct 27, 2025, After Close (Confirmed).

What is Medpace Holdings (MEDP) earnings time?

Medpace Holdings (MEDP) earnings time is at Oct 27, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MEDP EPS forecast?

MEDP EPS forecast for the fiscal quarter 2025 (Q3) is 3.53.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing